Alan D. Sobel - Feb 14, 2022 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role: Director
Signature: /s/ Kathleen P. Bloch attorney-in-fact for Alan D. Sobel
Stock symbol: CTSO
Transactions as of: Feb 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/15/2022, 03:31 PM
Next filing: May 12, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTSO	Common Stock	Gift	$0	+2K		$0.00	2K	Feb 14, 2022	Bernard Sobel Revocable Trust	F1
holding	CTSO	Common Stock						69.3K	Feb 14, 2022	Direct	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in the Bernard Sobel Revocable Trust (the "Trust'"). On February 14, 2022, the reporting person became a trustee of the Trust. The reporting person is also a named beneficiary of the Trust. Accordingly, the reporting person may be deemed the beneficial owner of the shares held in the Trust.
F2	Includes the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015.

Content

These shares are held in the Bernard Sobel Revocable Trust (the "Trust'"). On February 14, 2022, the reporting person became a trustee of the Trust. The reporting person is also a named beneficiary of the Trust. Accordingly, the reporting person may be deemed the beneficial owner of the shares held in the Trust.

Includes the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015.